Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.

The ANCOVA models confirmed that baseline weight alone was a marginally significant predictor of weight change at end point in the pramlintide [parameter estimate (SE) = −0.0194 (0.0088); P = 0.0276] and placebo [parameter estimate (SE) = −0.0196 (0.0096); P = 0.0420] groups.

also in 26,082 other papers